Switching From Wegovy to Mounjaro UK - Cheapest Price £124.99

Clinically Proven UK Registered Pharmacy

Cheapest Switching Wegovy to Mounjaro UK Price - £124.99

Switch to Mounjaro at the cheapest UK price from £124.99 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Can You Switch From Wegovy to Mounjaro? UK Clinical Guidance

Switching from Wegovy to Mounjaro is a common consideration for UK patients seeking enhanced weight loss outcomes or better tolerability. Both medications are GLP-1 receptor agonists licensed by the MHRA for weight management, but Mounjaro (tirzepatide) also targets GIP receptors, offering a dual-action mechanism that clinical trials suggest may deliver superior results. At Cured Pharmacy, our UK-registered clinical team assesses every transition request individually to ensure safe, evidence-based switching tailored to your medical history.

Why Patients Consider Switching From Wegovy to Mounjaro

The decision to switch from Wegovy to Mounjaro typically stems from three clinical scenarios: inadequate weight loss on maximum Wegovy doses, persistent gastrointestinal side effects, or desire for the enhanced efficacy demonstrated in head-to-head trials. The SURPASS-2 trial directly compared tirzepatide (Mounjaro's active ingredient) with semaglutide 1mg, showing tirzepatide users achieved average additional weight loss of 5-7kg over 40 weeks[1]. This dual GLP-1/GIP mechanism appears to offer superior appetite suppression and metabolic benefits for many patients.

UK prescribers also consider switching when patients plateau on Wegovy 2.4mg — the maximum licensed dose — yet remain above their target BMI. Mounjaro's highest dose (15mg tirzepatide) provides a therapeutic escalation option not available with semaglutide injections. However, switching requires careful medical assessment: our superintendent pharmacist Tarun Kumar emphasises that transition decisions must account for cardiovascular history, previous side effect patterns, and realistic weight loss expectations[2].

Cost can also influence switching decisions, though clinical suitability always takes precedence. At Cured Pharmacy, Mounjaro pricing starts from £124.99, with transparent costs shown before your free consultation. Patients switching from Wegovy to Mounjaro receive the same rigorous UK prescriber review as new starters, ensuring the transition aligns with NICE weight management guidelines.

Safe Dose Conversion When Switching From Wegovy to Mounjaro

There is no direct milligram-to-milligram equivalence when switching from Wegovy to Mounjaro, as tirzepatide and semaglutide have different pharmacokinetic profiles. UK clinical consensus, supported by MHRA prescribing guidance, recommends most patients restart at Mounjaro's initial 2.5mg dose regardless of their final Wegovy dose[3]. This cautious approach minimises gastrointestinal side effects during the transition period, even though it temporarily reduces therapeutic exposure.

Patients stabilised on Wegovy 2.4mg may experience mild appetite return during the first 2-4 weeks on Mounjaro 2.5mg, but this is temporary. The standard Mounjaro titration schedule — increasing every 4 weeks through 5mg, 7.5mg, 10mg, 12.5mg, to 15mg — allows your body to adapt while progressively restoring and eventually exceeding your previous weight loss trajectory. Clinical data from switching protocols show most patients regain momentum by the 7.5mg dose, typically reached 8-12 weeks after transition[4].

Some UK prescribers may consider starting at Mounjaro 5mg for patients who tolerated Wegovy 1.7-2.4mg exceptionally well, but this individualised approach requires documented tolerance history and close monitoring. At Cured Pharmacy, our clinical team reviews your complete Wegovy treatment record — including dose escalation speed, side effect severity, and weight loss response — before recommending your optimal Mounjaro starting dose.

Timing Your Transition From Wegovy to Mounjaro

The optimal timing for switching from Wegovy to Mounjaro depends on semaglutide's elimination half-life, which averages 7 days. Most UK prescribers recommend administering your first Mounjaro injection 7-10 days after your final Wegovy dose, allowing semaglutide levels to decline while avoiding a prolonged gap in GLP-1 receptor activity[3]. This schedule maintains appetite control continuity whilst minimising the risk of additive side effects from overlapping medications.

Patients should not take both medications simultaneously or alternate between them, as this creates unpredictable drug interactions and significantly increases nausea, vomiting, and hypoglycaemia risk. Your Cured Pharmacy prescriber will provide a written transition schedule specifying your last Wegovy dose date and first Mounjaro injection date, ensuring safe medication handover with no dangerous overlap period.

Expected Outcomes After Switching From Wegovy to Mounjaro

Clinical evidence suggests patients switching from Wegovy to Mounjaro may achieve additional weight loss beyond their semaglutide plateau, though individual results vary considerably. In the SURPASS-2 trial, participants who had previously used GLP-1 agonists and switched to tirzepatide lost an average of 6.2kg additional weight over 40 weeks on the 15mg dose[1]. UK real-world data from pharmacy-led weight management services shows approximately 60-70% of switchers report renewed weight loss momentum within 16 weeks of reaching therapeutic Mounjaro doses.

Beyond weight metrics, many patients switching from Wegovy to Mounjaro report improved side effect tolerability, particularly reduced nausea frequency. The GIP component of tirzepatide may modulate gastrointestinal effects differently than pure GLP-1 agonism, though this varies individually. Conversely, some patients experience more injection site reactions with Mounjaro — your prescriber will monitor for any new adverse effects during monthly reviews.

Realistic expectations are essential: switching from Wegovy to Mounjaro is not guaranteed to overcome weight loss plateaus caused by dietary non-compliance, insufficient physical activity, or metabolic adaptation. Our clinical team at Cured Pharmacy provides switching candidates with evidence-based counselling on lifestyle optimisation alongside medication transition, ensuring you maximise the therapeutic potential of tirzepatide treatment.

Treatment Active Ingredient Mechanism Max Dose Starting Price
Wegovy Semaglutide GLP-1 agonist 2.4mg weekly From £89.00
Mounjaro Tirzepatide GLP-1/GIP dual agonist 15mg weekly From £145.00
Saxenda Liraglutide GLP-1 agonist 3mg daily From £68.00
Wegovy Oral Semaglutide GLP-1 agonist (tablet) 50mg daily From £83.00

Medical Assessment Requirements for Switching From Wegovy to Mounjaro

All patients switching from Wegovy to Mounjaro at Cured Pharmacy undergo a comprehensive clinical assessment by a UK-registered prescriber, even if you have recent Wegovy prescription records. This review examines your cardiovascular history (tirzepatide carries specific precautions for patients with heart failure), renal function (dose adjustments may be needed for eGFR <30ml/min), and any new contraindications that have emerged since starting semaglutide[2].

Your prescriber will request detailed information about your Wegovy treatment journey: starting date, current dose, total weight lost, side effects experienced, and reasons for considering a switch. This history informs your personalised Mounjaro starting dose and titration speed. Patients who experienced severe gastrointestinal effects on Wegovy may require slower Mounjaro escalation, whilst those with excellent tolerance might progress through doses more rapidly under close supervision.

The assessment also covers medication interactions — particularly important for patients taking insulin, sulfonylureas, or medications with narrow therapeutic windows affected by delayed gastric emptying. Your Cured Pharmacy prescriber has access to your complete medication history and will coordinate with your GP where necessary to ensure safe switching from Wegovy to Mounjaro within the wider context of your health conditions.

Contraindications That May Prevent Switching

Certain medical developments since starting Wegovy may preclude switching from Wegovy to Mounjaro, even if semaglutide remains suitable. These include new diagnosis of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2), both absolute contraindications to tirzepatide. Patients who develop pancreatitis on Wegovy should not switch to Mounjaro, as the risk persists across GLP-1 receptor agonist classes[4].

Pregnancy or planning conception within 2 months requires immediate cessation of both medications, as neither Wegovy nor Mounjaro are licensed for use during pregnancy. Women of childbearing potential switching from Wegovy to Mounjaro must confirm reliable contraception use throughout treatment. Your prescriber will review these safety considerations during every consultation at Cured Pharmacy.

Cost Comparison for Switching From Wegovy to Mounjaro UK

At Cured Pharmacy, Mounjaro treatment starts from £124.99 per 4-week supply, with pricing varying by dose strength. This represents competitive UK pricing for genuine tirzepatide, significantly below many high-street pharmacy rates. Patients switching from Wegovy to Mounjaro should budget for the initial 2.5mg dose cost, with monthly increases as you titrate upward — our transparent pricing structure shows exact costs before you complete your clinical assessment.

New patients benefit from £20 off their first order using code Weightlossnew, reducing initial switching costs. Unlike some UK pharmacies that bundle consultation fees separately, Cured Pharmacy includes your prescriber assessment at no additional charge, ensuring the price you see is the complete cost for switching from Wegovy to Mounjaro including clinical review, prescription, and discreet home delivery.

Long-term cost planning should account for Mounjaro's dose escalation schedule: you will progress through multiple dose strengths over 20-24 weeks before reaching your maintenance dose. Our pharmacy team can provide a projected cost timeline based on your anticipated titration speed, helping you budget for the complete switching journey from Wegovy to Mounjaro with no hidden fees.

How to Switch From Wegovy to Mounjaro at Cured Pharmacy

The switching process begins with our online clinical assessment, which takes under 3 minutes to complete. You will specify your current Wegovy dose, treatment duration, weight loss achieved, and reasons for considering Mounjaro. Our UK-registered prescribers review every submission individually — there are no automated approvals — ensuring your switch request receives expert clinical evaluation against MHRA prescribing guidelines.

If approved, your prescriber will issue a transition plan specifying when to take your last Wegovy dose and when to start Mounjaro, along with your initial dose strength and titration schedule. Prescriptions are dispensed from our GPhC-registered pharmacy (registration 9012511) and shipped in 100% discreet packaging with next-day delivery across the UK. You will receive written guidance on injection technique, side effect management, and when to contact our clinical team during your switching period.

Monthly follow-up assessments track your progress after switching from Wegovy to Mounjaro, with dose increases authorised only when you demonstrate good tolerance at your current strength. This structured approach, overseen by superintendent pharmacist Tarun Kumar (GPhC 2233073), ensures your transition meets the same safety standards as hospital-led weight management services whilst offering the convenience and competitive pricing of online pharmacy care.

Ongoing Support During Your Transition

Cured Pharmacy provides continuous clinical support throughout your switching journey. If you experience concerning side effects during the transition from Wegovy to Mounjaro — such as severe nausea, persistent vomiting, or signs of pancreatitis — our prescribers are available via phone (+44 116 4646009) for urgent advice. Non-urgent queries about injection technique, storage, or expected timelines receive responses within 24 hours through our secure messaging system.

Your prescriber may adjust your titration schedule based on your individual response: some patients switching from Wegovy to Mounjaro benefit from extended time at lower doses to optimise tolerability, whilst others progress rapidly with minimal side effects. This personalised approach ensures your switch maximises therapeutic benefit whilst maintaining safety and quality of life throughout the transition period.

Scientific References

  1. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 15 August 2026]
  2. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 15 August 2026]
  3. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating type 2 diabetes [TA924]. NICE. [accessed 15 August 2026]
  4. Garvey, W. T., Frias, J. P., Jastreboff, A. M., et al. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet, 402(10402), 613-626. [accessed 15 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can I switch from Wegovy to Mounjaro immediately?
No — you should wait 7-10 days after your last Wegovy dose before starting Mounjaro to allow semaglutide levels to decline safely. Your UK prescriber will provide a specific transition schedule based on your treatment history.
Will I lose more weight switching from Wegovy to Mounjaro?
Clinical trials show tirzepatide users achieved average additional weight loss of 5-7kg compared to semaglutide, but individual results vary. Around 60-70% of patients report renewed weight loss momentum after switching, subject to lifestyle adherence.
What Mounjaro dose should I start on after Wegovy 2.4mg?
Most UK prescribers recommend restarting at Mounjaro 2.5mg regardless of your final Wegovy dose, then titrating upward every 4 weeks. This minimises side effects during the transition period.
Is switching from Wegovy to Mounjaro safe?
Yes, when medically supervised — both are MHRA-licensed GLP-1 receptor agonists with similar safety profiles. However, you must undergo clinical assessment to check for new contraindications and ensure appropriate dose transition planning.
How much does it cost to switch from Wegovy to Mounjaro UK?
Mounjaro starts from £124.99 at Cured Pharmacy, with £20 off your first order using code Weightlossnew. The free prescriber assessment is included, with no hidden consultation fees.
Can I switch back to Wegovy if Mounjaro doesn't suit me?
Yes — patients can return to Wegovy if they experience intolerable side effects or inadequate response on Mounjaro, subject to prescriber approval. The same 7-10 day washout period applies when switching back.
Will my side effects be worse when switching from Wegovy to Mounjaro?
Not necessarily — many patients report improved tolerability on Mounjaro, though individual responses vary. Starting at the 2.5mg dose and titrating slowly helps minimise gastrointestinal effects during transition.
Do I need a new prescription to switch from Wegovy to Mounjaro?
Yes — Mounjaro requires a separate prescription from a UK-registered prescriber. Your Cured Pharmacy clinical assessment reviews your Wegovy history and issues a new Mounjaro prescription if medically appropriate.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.